ストックスクリーナーアプリを入手
3.49
2.35%
0.08
アフターアワーズ：
3.49
前日終値:
$3.41
開ける：
$3.47
24時間の取引高:
1.62M
Relative Volume:
0.57
時価総額：
$942.27M
収益：
-
当期純損益:
$-244.17M
株価収益率:
-3.5747
EPS:
-0.9763
ネットキャッシュフロー:
$-144.77M
1週間 パフォーマンス:
+4.18%
1か月 パフォーマンス:
+9.06%
6か月 パフォーマンス:
-14.46%
1年 パフォーマンス:
+86.63%
1日の値動き範囲:
$3.37
$3.56
1週間の範囲:
$3.045
$3.56
52週間の値動き範囲:
$1.60
$6.55
Sana Biotechnology Inc Stock (SANA) Company Profile
名前
Sana Biotechnology Inc
セクター
電話
(206) 701-7914
住所
188 EAST BLAINE STREET, SUITE 350, SEATTLE
Compare SANA vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SANA
Sana Biotechnology Inc
|
3.49 | 920.67M | 0 | -244.17M | -144.77M | -0.9763 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 109.34B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 74.35B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 50.44B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 39.78B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.02B | 5.36B | 287.73M | 924.18M | 2.5229 |
Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-24 | 開始されました | Wedbush | Outperform |
| 2025-07-03 | 再開されました | Morgan Stanley | Overweight |
| 2025-03-18 | アップグレード | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-03-14 | 開始されました | Jefferies | Buy |
| 2025-01-08 | アップグレード | TD Cowen | Hold → Buy |
| 2024-11-05 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-06-26 | 開始されました | Rodman & Renshaw | Buy |
| 2024-01-16 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2023-09-25 | 開始されました | JMP Securities | Mkt Outperform |
| 2023-09-05 | 開始されました | Citigroup | Buy |
| 2023-08-14 | 開始されました | TD Cowen | Market Perform |
| 2023-05-02 | 開始されました | H.C. Wainwright | Neutral |
| 2021-03-01 | 開始されました | BofA Securities | Buy |
| 2021-03-01 | 開始されました | Goldman | Neutral |
| 2021-03-01 | 開始されました | JP Morgan | Neutral |
| 2021-03-01 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Sana Biotechnology Inc (SANA) 最新ニュース
Sana CEO Steve Harr to give business update in May 12 webcast - Stock Titan
Sana Biotechnology to Present at the BofA Securities 2026 Healthcare Conference - The Globe and Mail
MSN Money - MSN
SANA stock rallies 24% after hours — how much is Mayo Clinic investing in the company? - MSN
Sana Biotechnology (NASDAQ:SANA) Shares Down 7.3%Time to Sell? - MarketBeat
Sana Biotechnology abstract accepted for presentation at ASGCT By Investing.com - Investing.com India
Sana Biotechnology to present preclinical CAR-T data at May meeting - Investing.com
Sana Biotechnology abstract accepted for presentation at ASGCT - Investing.com
Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting - ChartMill
Sana Biotech surges as Eric Jackson calls it a 100-bagger - MSN
Sana Biotech (SANA), Mayo Clinic Partner to Advance Cell Therapy for Type 1 Diabetes - Yahoo Finance
Sana Biotech rises as Mayo Clinic partners for diabetes therapy - MSN
Sana Biotech Stock Jumps A Whopping 35% After Eric Jackson Calls It ‘Next 100-Bagger Platform’ - MSN
Wall Street Zen Downgrades Sana Biotechnology (NASDAQ:SANA) to Strong Sell - MarketBeat
Sana Biotechnology, Inc. ($SANA) President, CEO, and Director 2025 Pay Revealed - Quiver Quantitative
Sana Biotechnology, Inc. Files Form 8-K Current Report with SEC – Key Company Information and Details - Minichart
Sana Biotechnology | DEFA14A: Others - Moomoo
Sana Biotechnology reclassifies board member to balance director classes By Investing.com - Investing.com Australia
Sana Biotechnology Rebalances Board Classes With Director Shift - TipRanks
Sana Biotechnology reclassifies board member to balance director classes - Investing.com UK
Sana Biotechnology | DEF 14A: Definitive information statements - Moomoo
Sana Biotechnology (SANA) details 2026 virtual meeting, board elections and EY ratification - Stock Titan
Sana Biotechnology (SANA) Is Up 6.3% After Mayo-Backed SC451 Diabetes Cell Therapy CollaborationWhat's Changed - Sahm
Assessing Sana Biotechnology (SANA) Valuation After Mayo Clinic Partnership And Equity Investment - Yahoo Finance
Sana Biotechnology (SANA) Trading Range | Q4 2025: Earnings Fall ShortCommunity Sell Signals - Cổng thông tin điện tử Tỉnh Sơn La
Sana Biotechnology (SANA) Stock Stock Dividend (Grinds Lower) 2026-04-22Popular Trader Picks - Cổng thông tin điện tử tỉnh Lào Cai
Sana Biotechnology (SANA) Valuation Check After Mayo Clinic SC451 Collaboration And Recent Share Price Swing - Sahm
Sana Biotechnology Partners with Mayo Clinic for Diabetes Research - HarianBasis.co
Sana Biotechnology | 8-K: Current report - Moomoo
Wedbush Lifts PT on Sana Biotechnology (SANA) to $7 From $6 - Insider Monkey
Sana Biotechnology (NASDAQ:SANA) Stock Price Up 8.7%What's Next? - MarketBeat
10 Stocks Under $5 with Huge Upside Potential - Insider Monkey
Sana Biotechnology, Inc. (NASDAQ:SANA) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
SANA Should I Buy - Intellectia AI
Kailera Therapeutics Debut Marks Largest Biotech IPO Since 2021 Amid Weight Loss Race - Benzinga
Sana Biotechnology, Inc. (SANA) Stock Analysis: A Promising 147% Potential Upside in the Biotech Sector - DirectorsTalk Interviews
Sana Biotechnology Inc (SANA) 財務データ
収益
当期純利益
現金流量
EPS
0.14%
0.48%
大文字化:
|
ボリューム (24 時間):